ICU Medical (NASDAQ: ICUI)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-03 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 1.780 | 1.820 | 0.0400 | ||||
REV | 553.170M | 543.122M | -10.048M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of ICU Medical (NASDAQ: ICUI) through any online brokerage.
Other companies in ICU Medical’s space includes: RxSight (NASDAQ:RXST), Meihua International (NASDAQ:MHUA), Meridian Bioscience (NASDAQ:VIVO), BioLife Solns (NASDAQ:BLFS) and Embecta (NASDAQ:EMBC).
The latest price target for ICU Medical (NASDAQ: ICUI) was reported by Keybanc on Tuesday, May 10, 2022. The analyst firm set a price target for 265.00 expecting ICUI to rise to within 12 months (a possible 56.42% upside). 8 analyst firms have reported ratings in the last year.
The stock price for ICU Medical (NASDAQ: ICUI) is $169.42 last updated June 24, 2022, 8:00 PM UTC.
There are no upcoming dividends for ICU Medical.
ICU Medical’s Q2 earnings are confirmed for Wednesday, August 3, 2022.
There is no upcoming split for ICU Medical.
ICU Medical is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.